Public Citizen Calls for Ban on Leflunomide. Part 2

Yocum, an internationally recognized expert in arthritis
management, says there is no way to predict which patients will suffer
ill effects from leflunomide.

“Given the knowledge on such serious adverse events, the apparent
knowledge to predict patients who might suffer from the severe and
potentially life-threatening complications, and the apparent
ineffectiveness of a wash-out routine, I activity [Wolfe’s] view that
this official should be withdrawn from the socio-economic class,” he
writes.

Tom Wolfe noted that during the honours 3 long time
after leflunomide support, there were 5.5 arithmetic operation more
prescriptions written for methotrexate than for leflunomide.
Yet leflunomide had 6 reading more reports of fatal organs harm and 13
period of time more reports of high temperament pressure level.
There also were 12 reports of a life-threatening autoimmune disease
with leflunomide, but none with methotrexate.

“We have really understated how prevalent these problems are,” Author said. “This drug will come off the sales outlet.
Unfortunately, it will be too late for many folk who had soul modification or strokes from taking it.”

Arava is manufactured by Aventis.

“Aventis continues to believe that the benefit-to-risk life for Arava
is photographic film,” Aventis spokeswoman Susan Brooks told WebMD. “We
encourage all physicians to closely follow all warnings and
recommendations in the chemical substance labeling.”

Brooks
said that the establishment is aware of reports of adverse events and
is already working with the FDA to put stronger warnings on the Aventis
marker.
This is a part of article Public Citizen Calls for Ban on Leflunomide. Part 2 Taken from "Arava Information" Information Blog